BRIAN BERRYMAN: Open Payments
NPI 1184614919 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$831 in 43 payments from 14 companies in 2025. Trend: 2023 $119 · 2024 $419 · 2025 $831
Food & beverage: $831
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 9 | $170 |
| AstraZeneca Pharmaceuticals LP | 8 | $162 |
| Amgen Inc. | 4 | $87 |
| PFIZER INC. | 5 | $84 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $56 |
| Exact Sciences Corporation | 3 | $47 |
| Dexcom, Inc. | 2 | $42 |
| Astellas Pharma US Inc | 2 | $39 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $30 |
| Kite Pharma, Inc. | 1 | $30 |
Products named: BREZTRI, MOUNJARO, OTEZLA, CAPLYTA, Cologuard Collection Kit, Dexcom G6 Transmitter, Veozah, PREVNAR 20.
Industry payments across OK — which companies pay providers there.
